{
    "2020-03-18": [
        [
            {
                "time": "2020-03-18",
                "original_text": "复星医药(02196.HK)：控股股东增持计划已过半 累计增持0.28%股份",
                "features": {
                    "keywords": [
                        "复星医药",
                        "控股股东",
                        "增持",
                        "股份"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-03-30",
                "original_text": "复星医药(02196.HK)3月30日董事会考虑及通过全年业绩",
                "features": {
                    "keywords": [
                        "复星医药",
                        "董事会",
                        "全年业绩"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-03-18",
                "original_text": "港股异动︱与BioNTech强强联合共抗COVID-19 复星医药(02196)续涨逾8%",
                "features": {
                    "keywords": [
                        "复星医药",
                        "BioNTech",
                        "COVID-19",
                        "联合",
                        "上涨"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-03-18",
                "original_text": "法匹拉韦量产投入临床 医药股普涨四环医药涨近9%",
                "features": {
                    "keywords": [
                        "法匹拉韦",
                        "量产",
                        "临床",
                        "医药股",
                        "普涨"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-03-18",
                "original_text": "全国首款重组新冠疫苗背后的康希诺生物：已研发15种疫苗产品 正在冲击“A+H”",
                "features": {
                    "keywords": [
                        "新冠疫苗",
                        "康希诺生物",
                        "研发",
                        "A+H"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-03-18",
                "original_text": "美股新冠疫苗龙头暴涨66%! A股影子股起飞，疫苗距离上市还有多远",
                "features": {
                    "keywords": [
                        "新冠疫苗",
                        "美股",
                        "龙头",
                        "暴涨",
                        "A股",
                        "影子股"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}